Our aim to bring together leading academic scientists, researchers and research scholars to exchange and share their experiences and research results on all aspects of Toxicology and Applied Pharmacology.
To provide a premier interdisciplinary platform for researchers, practitioners and educators to present and discuss the most recent solutions adopted in the fields of Toxicology and Applied Pharmacology.
Abstract Submission Deadline
January 15, 2024
Early Bird Registration
December 10, 2023
September 19-21, 2024
We are pleased to announce that the International Conference on Toxicology & Applied Pharmacology (ICTAP-2024) will be held on September 19-21, 2024, Paris, France. The three-day conference will bring together leading scientists, researchers, and professionals from various fields of Toxicology and Applied Pharmacology, to share their latest findings, exchange ideas, and foster collaborations.
The main goal of the conference is to showcase the advances and challenges in Toxicology & Applied Pharmacology, in areas such as analytic toxicology, applied pharmacology, genotoxicity, forensic toxicology, clinical pharmacological, drug toxicity, drug delivery systems and more. The conference will feature plenary and keynote lectures by eminent experts, oral and poster presentations by participants, workshops and exhibitions by sponsors and exhibitors.
We cordially invite you to join us at ICTAP2024 and experience the beauty and culture of Paris, one of the most popular tourist destinations in the world. You will have the opportunity to network with your peers, learn from the experts, and discover new horizons in Toxicology and Applied Pharmacology
We look forward to welcoming you to Paris for this exciting and inspiring event in 2024!
Spandana J| Conference Secretary
University of ArizonaUSA
Extensive clinical experience providing bedside care as a medical toxicologist for both an adult and pediatric tertiary care academic medical center. Medical Toxicology is an ABMS-certified subspecialty with expertise in managing the care of patients with adverse health effects from prescription and over-the-counter medications, drugs of abuse, and other toxic exposures requiring a broad understanding of pathophysiology, pharmacology and causation. Will leverage my leadership skills, clinical experience, and subspecialty knowledge to advance the clinical application of pharmacogenomics and apply my expertise in pharmacology and toxicology to inform the development of safer, innovative products and pharmaceuticals, thus improving the lives and healthcare outcomes of a larger population. Experience leading and supporting diverse, multi-disciplinary teams and serving in key leadership positions for various institutional committees and national and state organizations. Expertise in developing and delivering educational content with the ability to target diverse audiences. Skilled in facilitating deeper understanding, open discussions, and debate among key stakeholders to support critical decision making. Adept at providing mentorship and professional development needs for burgeoning talent while promoting a strong foundation for interdisciplinary teams. Areas of interest include: pharmacogenetics, medication safety and pharmacovigilance, improving healthcare delivery and public health, forensic toxicology, promoting gender equality.
Lotus Holistic Healthcare Institute United Arab Emirates
Professor Dr. Mohammad Kamil, M.Sc.; M.Phil.; Ph.D.; D.Sc.; Chartered Chemist(U.K.) and Fellow Royal Society of Chemistry (London), has worked in various capacities. As In-charge -Drug Standardization lab. CCRUM, Ministry of Health -India, Associate Professor at Hamdard University, India; Professor & Head Department of Pharmacognostic Science, Zayed Complex for Herbal Research & Traditional. Medicine, Ministry of Health, UAE (1996-2010); Head TCAM Research at Department of Health, Abu Dhabi (2010-2020). Presently working as Director General, Lotus Holistic Healthcare Institute, Abu Dhabi, UAE since 2021. He is heading the Scientific Committee for the Sheikh Zayed International TCAM Awards. Actively engaged in research on Traditional Medicine, Medicinal Plants, since 1971. Research work conducted and guided research in the following fields: Chemistry of Natural Products; Quality control studies and standardization of herbal plants and products; Physicochemical & and pharmacognostic standards of single herbal medicine and composite herbal formulations; Screening of medicinal plants for phytomedicines; Medicinal chemistry; Phytochemical studies – Extraction, isolation, and characterization of chemical constituents using modern analytical techniques; Research in Traditional Complementary and Alternative Medicines; Adulteration of conventional medicines in herbal formulations for the safety of public health; Substantially contributed to Drug Research and standardized chemically about 400 Phyto pharmaceutical herbal preparations besides standardizing quite a huge number (over 600)of single herbal medicines; Isolated quite a large number of NOVEL compounds from medicinal plants and a completely New SERIES of bioflavonoids along with its synthesis for the first time in the world which appeared in peer-reviewed journals J.C.S (London), Chemistry & Industry (London).
University of New South WalesAustralia
A/Prof Kathy Wu is a HGSA-certified Clinical Geneticist, the founding Head of St Vincent's Clinical Genomics, an Adult Physician Scientist, MRFF researcher, and educator. Through her various roles affiliated with multiple universities and research institutions, including the UNSW, University of Sydney, University of Notre Dame Australia, The Garvan Institute of Medical Research and the George Institute for Global Research, she is committed to translating genomics research to inform precision healthcare and improving individual and categorical patient outcomes. She is one of the pioneers in Australia to lead a real-world pharmacogenomics implementation body of research and was awarded a multi-million dollar-MRFF Research Grant to conduct the ALIGNED trial, which is one of Australia’s first Double-Blind Randomised Controlled Trial on pharmacogenomics for people with Major Depressive Disorder
Indian Institute of Toxicology Research India
Nidhi Gupta is a senior scientist at CSIR-Indian Institute of Toxicology Research, Lucknow, India in Food, Drug, Chemical, Environment and System Toxicology division under Nanomaterial toxicology group. She received her master’s degree in Nanotechnology from Amity University with master’s dissertation on vaccine adjuvant nanoformulation at University of Queensland, Australia. She earned her PhD from Delhi Technological University, India on nano bioactive glass materials. She was CSIR - Senior Research Fellow (Direct) grant awardee as well as top rank holder in GATE and CSIR-UGC NET in Life Science. She has also gained experience on skin penetrating peptides at CSIR-Institute of Genomics and Integrative Biology, Delhi, India. She worked as a SERB Research Associate at Jawaharlal Nehru University, India gaining an understanding of the rheological properties of biopolymers. Further, she pursued her postdoctoral studies at the Institute of Nano Science and Technology, Mohali, where her research efforts focused on developing supramolecular biomimetic peptide hydrogels. For a short duration, she was also associated with the Indian Journal of Medical Science, a division of the Indian Council of Medical Research, an apex medical research body in India. Before, joining CSIR-IITR, she worked with the Department of Biomedical Engineering, University of Memphis, USA on antiinfective biomaterial formulations and animal model designing. The work accomplished so far has been published in high reputed journals (including ACS Chem. Mater., ACS Appl. Mater. Interface, ACS Mol. Pharm., J Control Release, JMC-B) as well as appreciated and awarded at various oral and poster presentations at International Conferences on Nanotechnology and adjuged best presentation award for the same by premier organizations such as The American Ceramic Society (BIOTEM 2021), Asia Polymer Association, Indian Society of Nano Medicine, AIIMS, Delhi, Manipal University, DBT and many more.
Central University Himachal Pradesh India
She held the post of Assistant Professor in the Department of Zoology, Ravenshaw University. She has 20 years of teaching and more than 15 years of research experience in the field of Cognitive Neuroscience. She has completed her Ph.D. in 2000 from Sambalpur University. She worked as a Postdoctoral Fellow in Human Stress Signal Research Center (HSS), Advanced Industrial Science and Technology (AIST), Kansai Center, Japan on Stress and Neuro-Developmental Disorders. She worked in the Central University of Hyderabad on Stem cell therapy in the Department of Animal Science. Later she moved to the Neurobiology Laboratory at Jawaharlal Nehru University, New Delhi, as a Women Scientist (DST, WOS “A”) Fellow and worked on “Cellular and Molecular Mechanism of Learning and Memory”. She is a life member of Indian Academy of Neuroscience (IAN), Society for Neurochemistry, India (SNCI) and Odisha Bigyan Academy (OBA). Her current research interest mainly focuses on gut microbiota and their interaction with brain, resulting changes in central nervous system function and cognitive behavior.
University of Belgrade Serbia
Dr. Mirjana B. Čolović, a senior research associate-chemical science, has been employed at University of Belgrade, Republic of Serbia, from 2005. Her research activities are in the field of enzymology, toxicology, biosensors, physiologically active compounds and their interactions with biomolecules, and the development of novel drug candidates. She published over 150 scientific contributions including 50 papers in impacted international journals, 5 chapters in books, 3 articles in national scientific journals, and over 100 abstracts/proceedings in scientific meetings. She served as a reviewer in over 40 international journals and 9 foreign projects, and as an editorial board member in 2 international journals. Her papers are cited over 2500 times. In 2021 and 2023 she was at USA Stanford University list of top 2% scientists in the world, based on a standardized citation metrics.
El-Manar University Tunisia
Messaoudi Abdelmonaem is a distinguished expert in Bioinformatics and Biostatistics with extensive academic and research experience. Holding a Ph.D. in Bioinformatics from El-Manar University, Tunisia, he has been an Assistant-Professor at the Higher Institute of Biotechnology of Beja, Jendouba University since 2013. Abdelmonaem's expertise extends to e-learning program management and quality assurance in academic settings. He has also contributed significantly to proteomics research and functional food preservation. With a background in microbiology and information technology, Abdelmonaem brings a unique multidisciplinary approach to his work. His commitment to advancing the field of toxicology and applied pharmacology is evident through his comprehensive skill set and continuous dedication to research and education.